Sign up to save your podcasts
Or
Share Dr Saad Highlights Results Following the ACIS Study
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Dr Saad Highlights Results Following the ACIS Study
Fred Saad, MD, University of Montreal Hospital Center, highlights, "Results from ACIS, a Randomized, Placebo Controlled Double-Blind Phase 3 Study of Apalutamide and Abiraterone Acetate Plus Prednisone Versus Abiraterone in Patients with Chemo-Naive Castration-Resistant Prostate Cancer."
View all episodes
By HMP GlobalFred Saad, MD, University of Montreal Hospital Center, highlights, "Results from ACIS, a Randomized, Placebo Controlled Double-Blind Phase 3 Study of Apalutamide and Abiraterone Acetate Plus Prednisone Versus Abiraterone in Patients with Chemo-Naive Castration-Resistant Prostate Cancer."